Chlamydia Infection Clinical Trial
Official title:
The Participant Agreement for Contact Tracing (PACT) Study: Enhancing Partner Notification Services.
Patients diagnosed with chlamydial infections (a sexually transmitted disease) are asked to notify their sex partners and tell them to seek medical evaluation. This project tests an enhancement to the materials provided to patients to help convince their partners to seek evaluation against the standard of care, which is a brief notification instruction. The desired outcomes are greater levels of notification by participants of their partners and lower levels of reinfection among participants.
Patients diagnosed with chlamydial infections (a sexually transmitted disease) are asked to
notify their sex partners and tell them to seek medical evaluation: patient referral. Rates
of actual referral by patients are unknown, but estimates derived from several evaluations
suggest somewhere between 30 - 55% of partners are notified and tested (for chlamydia).
Current prevalence and yearly rates of infection suggest this level of partner notification
and treatment is insufficient to control the disease.
As a program, this project has disseminated notification activities to community health
centers that see chlamydial infections, all under the aegis of the awardee (Boston Medical
Center). Diagnosis and partner notification can be recorded remotely , but centrally
accessed through a secure database. To enhance patient referral effectiveness, this project
tests brief instructions to refer (standard of care) against a "kit" containing a specific
notification of exposure to chlamydia, an accurate health message about the nature and
prognosis of the infection (treated and untreated), options for seeking free or low-cost
evaluation and treatment, and a satisfaction survey. A second, crossed condition is pure
patient referral against a contract (72 hours to notify, after which study staff will refer
cases to public health professionals for notification).
Principal outcomes measured are levels of notification by participants of their partners and
levels of reinfection among participants. We also measure psychosocial mediating effects, as
well as potential unintended consequences of patient referral: incident partner violence
against prevalent (baseline rates) violence, depressed affect
;
Allocation: Randomized, Endpoint Classification: Safety/Efficacy Study, Intervention Model: Factorial Assignment, Masking: Single Blind, Primary Purpose: Prevention
Status | Clinical Trial | Phase | |
---|---|---|---|
Terminated |
NCT00091728 -
Hormonal Contraception and Risk of Chlamydia and Gonorrhea
|
Phase 4 | |
Terminated |
NCT01291264 -
Use of Abbott RealTime CT/NG to Detect Chlamydia Trachomatis [CT] & Neisseria Gonorrhoeae [NG] in Men Who Have Sex With Men [MSM]
|
Phase 4 | |
Withdrawn |
NCT00578188 -
Chlamydia Trachomatis Persistence in the Female Gastrointestinal Tract
|
N/A |